Registration of resolutions adopted at Pharmexa's Ordinary General Meeting and Extraordinary General Meeting


With reference to Pharmexa's stock exchange release no. 21 published May 13,
2009, it can now be confirmed that the Danish Commerce and Companies Agency
have registered the resolutions adopted at the Ordinary General Meeting on
April 28, 2009 and the Extraordinary General Meeting on May 5, 2009. 

Pharmexa changes the company's name to Affitech A/S and the board of directors
in the company consists of Dr. Keith McCullagh (Chairman), Mr. Ole Steen
Andersen (Vice-Chairman), Mr. Steinar Engelsen, Mr. Arne Handeland, Mr. Påll
Rødseth and Mr. Michel Pettigrew. 

The registration of the capital increase in connection to the combination of
Affitech AS and Pharmexa A/S is expected to be registered within the next few
days when the transfer of the shares between  Affitech AS and Pharmexa A/S  has
been completed. 


Hørsholm, June 2, 2009


Achim Kaufhold
Chief Executive Officer


Additional information:
Claude Mikkelsen, Senior Vice President, Finance & Investor Relations, tel +45
4516 2525 or +45 4060 2558

Attachments

pharmexa press release 2009-24-uk.pdf